Topical Pimecrolimus 1% Cream for Resistant Seborrheic Dermatitis of the Face An Open-Label Study

---

GÜLER ÖZDEN M., SOLAK TEKİN N., İLTER N., Ankarali H.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, cilt.11, sa.1, ss.51-54, 2010 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 11 Sayı: 1
• Basım Tarihi: 2010
• Doi Numarası: 10.2165/11311160-000000000-00000
• Dergi Adı: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.51-54
• Gazi Üniversitesi Adresli: Evet

Özet

Background: Treatment options for seborrheic dermatitis are numerous, including both topical and systemic agents (e.g. topical corticosteroids, oral antifungals, and psoralen plus UVA). However, long-term use of topical corticosteroids may lead to adverse effects. Pimecrolimus 1% cream is an effective and well tolerated treatment for seborrheic dermatitis.